Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
641,637
Value
$321.7M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of TMO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026641,637$321.7M0.2%+338,789+111.9%AddedHolders
Q1 2026302,848$148.9M0.1%+255,305+537.0%AddedHolders
Q4 202547,543$27.5M<0.1%−16,913−26.2%ReducedHolders
Q3 202564,456$31.3M<0.1%−1,261,516−95.1%ReducedHolders
Q2 20251,325,972$537.6M0.5%+1,090,601+463.4%AddedHolders
Q1 2025235,371$117.1M0.1%−307,955−56.7%ReducedHolders
Q4 2024543,326$282.7M0.3%+205,477+60.8%AddedHolders
Q3 2024337,849$209.0M0.3%+136,585+67.9%AddedHolders
Q2 2024201,264$111.3M0.2%+143,588+249.0%AddedHolders
Q1 202457,676$33.5M<0.1%−44,821−43.7%ReducedHolders
Q4 2023102,497$54.4M0.1%−114,846−52.8%ReducedHolders
Q3 2023217,343$110.0M0.2%−52,575−19.5%ReducedHolders
Q2 2023269,918$140.8M0.2%+225,195+503.5%AddedHolders
Q1 202344,723$25.8M<0.1%−23,716−34.7%ReducedHolders
Q4 202268,439$37.7M0.1%−266,942−79.6%ReducedHolders
Q3 2022335,381$170.1M0.3%+95,664+39.9%AddedHolders
Q2 2022239,717$130.2M0.2%−132,921−35.7%ReducedHolders
Q1 2022372,638$220.1M0.3%−152,173−29.0%ReducedHolders
Q4 2021524,811$350.2M0.4%−4,094−0.8%ReducedHolders
Q3 2021528,905$302.2M0.4%+307,070+138.4%AddedHolders
Q2 2021221,835$111.9M0.1%−52,972−19.3%ReducedHolders
Q1 2021274,807$125.4M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.